Buchumschlag

The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Aqeem Azam, Peter James Barry, Rowland J. Bright‐Thomas, Alex Horsley, Andrew M. Jones
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Pediatric Pulmonology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
von: Elizabeth Clarke, et al.
Veröffentlicht: (2024)

Effect of Camel Milk on the Spirometry Parameters of Children With Cystic Fibrosis: The First Double Blind Randomized Clinical Trial
von: Seyed Javad Sayedi, et al.
Veröffentlicht: (2025)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
von: Cindy L. Williams, et al.
Veröffentlicht: (2025)

Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis
von: Jordana E. Hoppe, et al.
Veröffentlicht: (2025)

Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
von: Chelsea Flora, et al.
Veröffentlicht: (2026)

Commentary on “Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis”
von: Ahmet Kağan Özkaya, et al.
Veröffentlicht: (2025)

Randomized Cross‐Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia
von: Anna Charlotte Schoop, et al.
Veröffentlicht: (2025)

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis
von: Lauren N. Kormelink, et al.
Veröffentlicht: (2024)

Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
von: Gabriela R. Oates, et al.
Veröffentlicht: (2025)

Sleep‐Disordered Breathing in Cystic Fibrosis in Low‐ and Middle‐Income Countries
von: Merve Selçuk Balcı, et al.
Veröffentlicht: (2026)

The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
von: Rebecca J. Vitale, et al.
Veröffentlicht: (2026)

Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use
von: Khizra Farhan Ahmad, et al.
Veröffentlicht: (2026)

Feeding the Need: A Study on Food Security Among People With Cystic Fibrosis in Turkey
von: Damla Kocaman, et al.
Veröffentlicht: (2025)

C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations
von: Jonathan B. Zuckerman, et al.
Veröffentlicht: (2025)

Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Quality of Life in Children With Cystic Fibrosis
von: Sara Kümmerli, et al.
Veröffentlicht: (2026)

Plasma Microbial Cell‐Free DNA Metagenomic Next‐Generation Sequencing in People With Cystic Fibrosis
von: Mollie G. Wasserman, et al.
Veröffentlicht: (2024)

Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
von: Burcu Uzunoglu, et al.
Veröffentlicht: (2025)

Pathophysiology of Cystic Fibrosis Liver Disease
von: Vania L. Kasper, et al.
Veröffentlicht: (2024)

Roadmap to Global Cystic Fibrosis Care
von: Samya Z. Nasr, et al.
Veröffentlicht: (2025)

Cystic Fibrosis Year in Review 2024
von: Adrienne P. Savant
Veröffentlicht: (2025)

Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children
von: Lilah D. Melzer, et al.
Veröffentlicht: (2025)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
von: Senthilkumar Sankararaman, et al.
Veröffentlicht: (2025)

Expanding the Impact of New Cystic Fibrosis Therapies in Low‐ and Middle‐Income Countries
von: Eitan Kerem
Veröffentlicht: (2024)

Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
von: Rebecca Gallardo, et al.
Veröffentlicht: (2026)

Acceptability of Telehealth Post‐Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis
von: Jaclyn Davis, et al.
Veröffentlicht: (2025)

Expanding Cystic Fibrosis Registries to the Rest of the World
von: Lutz Naehrlich
Veröffentlicht: (2026)

The Dutch Gastrointestinal Symptom Tracker for People With Cystic Fibrosis: Associations With Anxiety, Depression, and Health‐Related Quality of Life
von: Marieke Verkleij, et al.
Veröffentlicht: (2025)

Real World Adverse Effects of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis Ages 6–11 Years
von: Rebecca S. Pettit, et al.
Veröffentlicht: (2025)

Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis
von: Rebecca S. Pettit, et al.
Veröffentlicht: (2025)

Co‐Design of a Novel Telehealth Exercise Model of Care for Adults With Cystic Fibrosis
von: Megan Poulsen, et al.
Veröffentlicht: (2026)

Objectively Monitored Sleep in School‐Age Children With Cystic Fibrosis and Their Parents
von: Andrea L. Fidler, et al.
Veröffentlicht: (2025)

Spirometry Assessments in Children With Sickle Cell Disease in Ghana
von: Baah Agyeiwah Birgit, et al.
Veröffentlicht: (2026)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
von: Bulent Karadag
Veröffentlicht: (2026)

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
von: Tuğba Şişmanlar Eyüboğlu, et al.
Veröffentlicht: (2026)

A Joint Conversation: People With Cystic Fibrosis' Perception of Healthcare Teams' Knowledge, Comfort, and Barriers in Discussing Substance Use
von: Sanaz Vaziri, et al.
Veröffentlicht: (2025)

Survey Validation of Exercise and Body Composition Testing and Exercise Training Programs for People With Cystic Fibrosis: A Delphi Study
von: Najlaa Z. Alotaibi, et al.
Veröffentlicht: (2025)

Transforming Care in Cystic Fibrosis: The Long‐Term Impact of Quality Improvement Projects on Clinical Outcomes
von: S. Karabulut, et al.
Veröffentlicht: (2026)

Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis
von: Hillary S. Hayden, et al.
Veröffentlicht: (2025)

Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
von: Laurie P. Murray, et al.
Veröffentlicht: (2025)

E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
von: Maryam Sahibqran, et al.
Veröffentlicht: (2024)